Compounds > 3,4-methylenedioxyethamphetamine

Page last updated: 2024-08-26

3,4-methylenedioxyethamphetamine and Nervous System Disorders

3,4-methylenedioxyethamphetamine has been researched along with Nervous System Disorders in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freudenmann, RW; Spitzer, M	1
Merrill, J	1
Saunders, N	1
King, LA; Winstock, AR	1
Laverty, R; Logan, BJ; Sanderson, WD; Yee, YB	1

Reviews

1 review(s) available for 3,4-methylenedioxyethamphetamine and Nervous System Disorders

Article	Year
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). CNS drug reviews, 2004,Summer, Volume: 10, Issue:2 Topics: 3,4-Methylenedioxyamphetamine; Animals; Drug Administration Schedule; Drug Interactions; Europe; Hallucinogens; Humans; Illicit Drugs; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Neurotoxins; North America	2004

Other Studies

4 other study(ies) available for 3,4-methylenedioxyethamphetamine and Nervous System Disorders

Article	Year
Ecstasy and neurodegeneration. Advice is that "less is more". BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054 Topics: 3,4-Methylenedioxyamphetamine; Chronic Disease; Designer Drugs; Humans; Nervous System Diseases; Risk Factors	1996
Ecstasy and neurodegeneration. No evidence of neurotoxicity exists. BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054 Topics: 3,4-Methylenedioxyamphetamine; Brain Diseases; Chronic Disease; Designer Drugs; Humans; Nervous System Diseases	1996
Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy... BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054 Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Drug Contamination; Humans; Nervous System Diseases; Tablets	1996
Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. European journal of pharmacology, 1988, Aug-02, Volume: 152, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Monoamines; Dopamine; Male; Methoxyhydroxyphenylglycol; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Norepinephrine; Rats; Species Specificity	1988